GlassScriptPhysician profile
Gary W Clarkson
NPI 1841488376
$1,085.01
in general payments reported to CMS, 2019-2025
10 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $493 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $439.76 | 2024-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Mimedx Group, INC. | $350.18 | 2024-2025 | |
| Smith+Nephew, INC. | $115.92 | 2024-2025 | Collagenase Santyl, Regranex |
| Lifenet Health | $46.07 | 2025 | Theragenesis Wound Matrix |
| Convatec INC. | $40.90 | 2024-2025 | |
| Solventum Corporation | $25.84 | 2024 | Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $21.30 | 2024 | Nuzyra |
| Bsn Medical INC | $17.18 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $16.26 | 2024 | |
| Molnlycke Health Care US, LLC | $11.60 | 2024 | Mepilex Border Sacrum, Mepilex Lite, Mepilex Border Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Clarkson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.